Sirolimus for Autoimmune Disease of Blood Cells

Clinical trial NCT00392951 · COMPLETED

Trial details

NCT number: NCT00392951
Sponsor: Children's Hospital of Philadelphia
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Autoimmune Pancytopenia Autoimmune Lymphoproliferative Syndrome (ALPS)Evans Syndrome Idiopathic Thrombocytopenic Purpura Anemia, Hemolytic, Autoimmune Autoimmune Neutropenia Lupus Erythematosus, Systemic Inflammatory Bowel Disease Rheumatoid Arthritis

Start date: 2006-12-01
Primary completion: 2016-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.